Intraoperative PEEP Optimization: Effects on Postoperative Pulmonary Complications and Inflammatory Response
3 other identifiers
interventional
40
1 country
2
Brief Summary
The purpose of this prospective randomized controlled trial is to determine the effects of intraoperative lung protective mechanical ventilation using an individual optimal PEEP value on postoperative pulmonary complications and inflammatory response. A total number of 40 patients undergoing open radical cystectomy and urinary diversion will be enrolled and randomized into two groups. Standard lung protective ventilation using a PEEP of 6 cmH2O will be performed in control group and an optimal PEEP value determined during a static pulmonary compliance (Cstat) directed PEEP titration procedure will be applyed in study group. Low tidal volumes (6mL/Kg IBW) and a fraction of inspired oxygen (FiO2) of 0.5 will be applyed in both groups. Procalcitonin kinetics will be monitored during and after surgery until the third postoperative day as well as postoperative pulmonary complications. Clinical condition and extrapulmonary complications will be evaluated by the Sequential Organ Failure Assessment (SOFA) Score and in-hospital stay, 28-days and in-hospital mortality will also be followed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2016
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 5, 2016
CompletedFirst Posted
Study publicly available on registry
October 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedApril 2, 2019
April 1, 2019
2.5 years
October 5, 2016
April 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative Pulmonary Complications
New infiltrates or atelectasis on chest X-ray, abnormal breathing sounds on auscultation, excessive bronchial secretions, unexplained fever, respiratory failure defined as PaO2/FiO2 \< 300 or need for non-invasive or invasive ventilatory support.
72 hours
Procalcitonin Kinetics
Serum procalcitonin levels during and after surgery.
72 hours
Secondary Outcomes (5)
Incidence of Circulatory Failure
28 days
Incidence of Gastrointestinal Dysfunctions
28 days
Incidence of Renal Dysfunction
28 days
Incidence of Hematologic and Coagulation Disorders
72 hours
Infection
28 days
Other Outcomes (3)
ICU days
28 days
In-hospital Stay
28 days
Mortality
28 days
Study Arms (2)
Optimal PEEP
EXPERIMENTALPatients submitted to general anesthesia and open radical cystectomy and urinary diversion (20 subjects) will be submitted an alveolar recruitment maneuver using the sustained airway pressure by the CPAP method, applying 30 cmH2O PEEP for 30 seconds followed by a decremental PEEP titration procedure directed by static pulmonary compliance (Cstat). During PEEP titration procedure PEEP will be decreased from 14 cmH2O by 2 cmH2O every 4 minutes, until a final PEEP of 6 cmH2O. Optimal PEEP is considered as a PEEP value resulting the highest possible Cstat measured by ventilator. After PEEP titration procedure a lung protective mechanical ventilation will be performed using optimal PEEP and low tidal volumes (6 mL/Kg IBW).
Standard PEEP
ACTIVE COMPARATORPatients submitted to general anesthesia and open radical cystectomy and urinary diversion (20 subjects) will be submitted an alveolar recruitment maneuver using the sustained airway pressure by the CPAP method, applying 30 cmH2O PEEP for 30 seconds followed by a standard lung protective mechanical ventilation using a PEEP value of 6 cmH2O and low tidal volumes (6 mL/Kg).
Interventions
Lung protective mechanical ventilation applying a PEEP value of 6 cmH2O
Eligibility Criteria
You may qualify if:
- Patients with bladder cancer undergoing radical cystectomy and urinary diversion (ileal conduit or orthotopic bladder substitute)
You may not qualify if:
- Age \< 18 years
- ASA grade IV
- History of severe chronic obstructive pulmonary disease (COPD, GOLD grade III or IV)
- History of severe or uncontrolled bronchial asthma
- History of severe restrictive pulmonary disease
- Pulmonary metastases
- History of any thoracic surgery
- Need for thoracic drainage before surgery
- Renal replacement therapy prior to surgery
- Congestive heart failure (NYHA grade III or IV)
- Extreme obesity (BMI \> 35 Kg/m2)
- Lack of patient's consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Péterfy Sándor Hospitallead
- Szeged Universitycollaborator
Study Sites (2)
University of Szeged, Faculty of Medicine, Department of Anaesthesiology and Intensive Therapy
Szeged, Csongrád megye, 6722, Hungary
Péterfy Sándor Hospital
Budapest, Pest County, 1076, Hungary
Related Publications (2)
Ruszkai Z, Kiss E, Laszlo I, Bokretas GP, Vizseralek D, Vamossy I, Surany E, Buzogany I, Bajory Z, Molnar Z. Effects of intraoperative positive end-expiratory pressure optimization on respiratory mechanics and the inflammatory response: a randomized controlled trial. J Clin Monit Comput. 2021 May;35(3):469-482. doi: 10.1007/s10877-020-00519-6. Epub 2020 May 9.
PMID: 32388650DERIVEDRuszkai Z, Kiss E, Laszlo I, Gyura F, Surany E, Bartha PT, Bokretas GP, Racz E, Buzogany I, Bajory Z, Hajdu E, Molnar Z. Effects of intraoperative PEEP optimization on postoperative pulmonary complications and the inflammatory response: study protocol for a randomized controlled trial. Trials. 2017 Aug 11;18(1):375. doi: 10.1186/s13063-017-2116-z.
PMID: 28800778DERIVED
Study Officials
- STUDY DIRECTOR
Zsolt Molnár, Prof, MD, PhD, DEAA
University of Szeged, Faculty of Medicine, Department of Anaesthesiology and Intensive Therapy
- PRINCIPAL INVESTIGATOR
Zoltán Ruszkai, MD
Péterfy Sándor Hospital, Department of Anaesthesiology and Intensive Care
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Head of Department of Anaesthesiology and Intensive Care
Study Record Dates
First Submitted
October 5, 2016
First Posted
October 13, 2016
Study Start
October 1, 2016
Primary Completion
March 31, 2019
Study Completion
March 31, 2019
Last Updated
April 2, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share
IPD are not relevant in terms of results.